Northwest Biothrputcs Inc (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 111 | 329 | 160 | 255 | 664 |
| Receivables | 37 | 7 | 46 | 8 | 61 |
| TOTAL | $173 | $383 | $298 | $348 | $833 |
| Non-Current Assets | |||||
| PPE Net | 186 | 299 | 336 | 373 | 402 |
| Other Non-Current Assets | 75 | 75 | 75 | 150 | 150 |
| TOTAL | $261 | $374 | $411 | $523 | $552 |
| Total Assets | $434 | $757 | $709 | $871 | $1,385 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 339 | 334 | 268 | 128 | 109 |
| Accrued Expenses | 681 | 557 | 638 | 526 | 594 |
| Other current liabilities | 2,146 | N/A | N/A | N/A | N/A |
| TOTAL | $5,052 | $1,375 | $1,302 | $740 | $751 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 39 | 105 | 207 | N/A | N/A |
| Other Non-Current Liabilities | 54 | 59 | 61 | 66 | 61 |
| TOTAL | $72 | $87 | $99 | $115 | $120 |
| Total Liabilities | $5,124 | $1,462 | $1,401 | $855 | $871 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 79 | 79 | 79 | 79 | 79 |
| Common Shares | 19 | 19 | 19 | 19 | 19 |
| Retained earnings | -68,360 | -66,091 | -65,072 | -64,244 | -63,372 |
| Other shareholders' equity | -20 | -27 | -33 | -53 | -89 |
| TOTAL | $-4,690 | $-705 | $-692 | $16 | $514 |
| Total Liabilities And Equity | $434 | $757 | $709 | $871 | $1,385 |